Patient centricity and cross-functional collaboration are the foundation of rare disease markets. Our proven strategies help ensure your product delivers value to both stakeholders and patients. Hear from our experts Dr. Kapil Raina, Brian Williams, and Chris Zealey: https://lnkd.in/eWi_rfB4 #MarketAccess #MedicalAffairs #LaunchExcellence #AskHerspiegel
sixsense strategy group
Business Consulting and Services
insights. strategy. life sciences.
About us
WHO WE ARE: sixsense strategy group is a boutique consulting company with a singular focus on the life sciences industry. Our strategists and scientists collaborate to provide a unique and refreshing approach to strategy. WHERE WE WORK: Our work is global - over the past 15 years we have worked in the USA, EU, and Canada. OUR SWEETSPOT: While we work with a breadth of clients, our sweetspot is companies that are launching new therapies / entering new disease areas that are looking for strategic partners to help ensure successful entry. Follow Us On Social Media: Twitter / Instagram - @sixsenseinc
- Website
-
http://www.sixsenseinc.com
External link for sixsense strategy group
- Industry
- Business Consulting and Services
- Company size
- 11-50 employees
- Headquarters
- Toronto
- Type
- Privately Held
- Founded
- 2004
- Specialties
- Customer Insight, Business Strategy, Sales Strategy Design and Training, Organizational Effectiveness, Process Design and Implementation, Executive and Team Coaching
Locations
-
Primary
18 King St East
Mezzanine Level
Toronto, M5C 1C4, CA
Employees at sixsense strategy group
-
Tom Hendrikson
-
Nicole Ritter
Medical Communications Consultant | Ph.D. in Biological and Chemical Sciences | Confident leader, learner, and communicator
-
Luba Slatkovska
Medical communications expert with a passion for enabling patient care improvements through strategically-guided evidence generation and dissemination
-
Tyler Vance
Medical Communications Associate
Updates
-
Transform patient outcomes with support programs that deliver real results. From development to delivery, we help improve patient adherence, eliminate barriers, and demonstrate value. Read here: https://lnkd.in/eRgTxq_3 #PatientServices #AskHerspiegel
-
In the rare disease space, every launch decision counts. Transform complexity into a strategy to navigate expedited pathways, manage risk, and avoid launch delays. Hear from our experts Dr. Kapil Raina, Brian Williams, and Chris Zealey: https://lnkd.in/eYHYwDS5 #MarketAccess #MedicalAffairs #LaunchExcellence #AskHerspiegel
-
Launch archetypes are critical to navigating the complexities of rare disease markets. Read how patient-centric models help optimize product performance and successful market entry: https://lnkd.in/gGpuPHJ3 #LaunchExcellence #MarketingExcellence #RareDisease #AskHerspiegel
-
We're excited to welcome Zachary Zimmerman as a Senior Consultant on the Delivery team! Zach brings valuable experience in competitive intelligence consulting within the pharmaceutical sector, with expertise spanning general medicine, oncology, metabolism, and obesity. Join us in welcoming Zach to the team! #AskHerspiegel #LifeAtHerspiegel #Growth
-
We’re excited to welcome Andrew Toye Ojo, PhD as a Senior Science and Strategy Consultant to the Medical Affairs team! Toye is passionate about driving strategic business recommendations and advancing patient outcomes through data insights. Join us in welcoming Toye to the team! #lifeatherspiegel #AskHerspiegel #growth #SSG
-
We’re excited to welcome Sarah Skinner, PhD as a consultant to the Commercial Delivery team! Sarah brings valuable experience in life sciences consulting, with expertise in oncology, rare diseases, and competitive intelligence. Join us in welcoming Sarah to the team! #AskHerspiegel #lifeatHerspiegel #growth
-
We are excited to welcome Yvonne Kemps as a Senior Consultant on the Delivery team! With her extensive experience in the pharmaceutical and biotech sectors, Yvonne brings valuable expertise in innovations, growth strategies, regulatory approval, market access, and women’s health projects. Please join us in welcoming Yvonne to the team!
-
Dr. Kapil Raina, Brian Williams, and Chris Zealey share launch planning best practices for rare disease therapies, including budgeting, resource allocation, and stakeholder engagement strategies: https://lnkd.in/eSa2tdzX #AskHerspiegel #CommercialConversation #RareDisease #LaunchPlan
-
Our commercial, medical, and market access experts Dr. Kapil Raina, Brian Williams, and Chris Zealey outline key factors for success in rare disease markets, focusing on a patient-centered approach: https://lnkd.in/e6TNWx_P #AskHerspiegel #RareDisease #MarketAccess #MedcialAffairs #Commercialization